As of November 2024 Immunovant has a market cap of $3.92 Billion USD. This makes Immunovant the world's 3115th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 14th, 2024 the market cap of Immunovant was reported to be: